NCT02028949View on ClinicalTrials.gov

Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 22, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

February 5, 2016

Conditions
Unresectable Non-metastatic Hepatocellular CarcinomaChild A/B7 Cirrhosis
Interventions
DRUG

Zavedos®

OTHER

Blood samples

Trial Locations (1)

21079 Cedex

CHU de Dijon, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02028949 - Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study | Biotech Hunter | Biotech Hunter